Pantoprazole: from drug metabolism to clinical relevance

Expert Opinion on Drug Metabolism & Toxicology
Marc Bardou, Janet Martin

Abstract

Conditions requiring inhibition of acid secretion, such as gastro-oesophageal reflux disease (GORD), peptic ulcers, non-ulcer dyspepsia or the use of NSAIDs, are very common, and their prevalence is expecting to rise as they are seen predominantly amongst the elderly. Among the drugs available to inhibit acid secretion, proton pump inhibitors (PPI) have been shown to have the best efficacy-safety ratio and have been used widely. This paper was intended to provide an overall presentation of one of these PPIs, pantoprazole. This study was first intended to give an overview of pantoprazole, so a Medline search was conducted using pantoprazole as unique search term, without publication date restriction. We found 826 references for pantoprazole and selected some of the most relevant publications to conduct this review. Five different PPIs are commercially available: omeprazole, pantoprazole, rabeprazole, lansoprazole and esomeprazole. Pantoprazole differs from other PPIs by a selective binding to the ion transport pathway, a good stability at neutral pH values, and a relatively robust plasma concentration-time curve. These pharmacokinetic differences may not be fully converted into pharmacodynamic differences of pantoprazole versus ...Continue Reading

References

Oct 1, 1996·European Journal of Gastroenterology & Hepatology·K D Bardhan
Jun 12, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·V KliemW Wurst
Jan 16, 1999·Baillière's Clinical Gastroenterology·G R Locke
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Mar 17, 2004·Alimentary Pharmacology & Therapeutics·H B El-Serag, N J Talley
Apr 21, 2004·European Journal of Gastroenterology & Hepatology·Javier P GisbertJosé María Pajares
Aug 25, 2004·Best Practice & Research. Clinical Gastroenterology·Enrico Corazziari
Oct 14, 2004·Alimentary Pharmacology & Therapeutics·K D BardhanH Mönnikes
Oct 23, 2004·Biochemical Pharmacology·Jai Moo Shin, George Sachs
Jan 14, 2005·European Journal of Gastroenterology & Hepatology·William C Orr
Feb 5, 2005·Alimentary Pharmacology & Therapeutics·O Diav-CitrinA Ornoy
Mar 1, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·L B Gerson, G Triadafilopoulos
Mar 18, 2005·Alimentary Pharmacology & Therapeutics·M BardouA N Barkun
Aug 5, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·M FornaiM Del Tacca
May 17, 2006·Alimentary Pharmacology & Therapeutics·G SachsC W Howden
Jun 27, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·P KirchhoffJ P Geibel
Jul 5, 2006·The American Journal of Gastroenterology·Jaroslaw RegulaRenate Fischer
Jul 13, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Angela AbelöMats O Karlsson
Sep 12, 2006·International Journal of Clinical Pharmacology and Therapeutics·U Klotz
Sep 14, 2006·The American Journal of Gastroenterology·Dennis M JensenUNKNOWN 315 Study Group
Oct 25, 2006·Alimentary Pharmacology & Therapeutics·M JalvingJ H Kleibeuker
Dec 21, 2006·International Journal of Clinical Pharmacology and Therapeutics·E SalgueiroG Manso
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Yu-Xiao YangDavid C Metz
Jan 5, 2007·Journal of Gastroenterology and Hepatology·Pedro González CarroFrancisco Ruíz Carrillo

❮ Previous
Next ❯

Citations

Mar 13, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gregory L KearnsAndrea Gaedigk
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jul 16, 2014·Expert Opinion on Drug Metabolism & Toxicology·Françoise GoirandMarc Bardou
Dec 9, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Renata P RaffinSilvia S Guterres

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Veterinary Internal Medicine
G W SmithD M Foster
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
R P RaffinS S Guterres
© 2022 Meta ULC. All rights reserved